⌘K
Loading ticker…
ProShares Ultra Health Care · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, ProShares Ultra Health Care (RXL) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 2.4%, relative volume 1.01×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | LLY | 12.67% | $9M |
| 2 | IQMM | 11.81% | $9M |
| 3 | JNJ | 7.86% | $6M |
| 4 | ABBV | 5.57% | $4M |
| 5 | UNH | 4.98% | $4M |
| 6 | MRK | 4.26% | $3M |
| 7 | TMO | 2.68% | $2M |
| 8 | AMGN | 2.62% | $2M |
| 9 | GILD | 2.41% | $2M |
| 10 | ISRG | 2.18% | $2M |
| 11 | PFE | 2.15% | $2M |
| 12 | ABT | 2.15% | $2M |
| 13 | BMY | 1.68% | $1M |
| 14 | CVS | 1.67% | $1M |
| 15 | DHR | 1.66% | $1M |
| 16 | VRTX | 1.64% | $1M |
| 17 | SYK | 1.52% | $1M |
| 18 | Medtronic plc | 1.37% | $987K |
| 19 | MCK | 1.32% | $948K |
| 20 | ELV | 1.26% | $905K |
| 21 | CI | 1.06% | $762K |
| 22 | BSX | 1.04% | $747K |
| 23 | REGN | 0.90% | $646K |
| 24 | HCA | 0.86% | $618K |
| 25 | Cencora, Inc. | 0.76% | $547K |
Showing 25 of 59 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RXL Jan avg: 3.79% median: 2.54% win: 50% σ: 7.51% n: 4 2022-04-12 → 2026-07-31 | RXL Feb avg: 1.47% median: 4.08% win: 75% σ: 7.16% n: 4 2022-04-12 → 2026-07-31 | RXL Mar avg: -3.69% median: -1.10% win: 50% σ: 9.39% n: 4 2022-04-12 → 2026-07-31 | RXL Apr avg: -5.69% median: -7.75% win: 20% σ: 7.97% n: 5 2022-04-12 → 2026-07-31 | RXL May avg: -2.10% median: 2.08% win: 60% σ: 7.60% n: 5 2022-04-12 → 2026-07-31 | RXL Jun avg: 4.23% median: 3.22% win: 80% σ: 6.81% n: 5 2022-04-12 → 2026-07-31 | RXL Jul avg: 1.77% median: 3.83% win: 80% σ: 5.53% n: 5 2022-04-12 → 2026-07-31 | RXL Aug avg: 1.67% median: 3.85% win: 50% σ: 10.37% n: 4 2022-04-12 → 2026-07-31 (current) | RXL Sep avg: -3.68% median: -5.27% win: 25% σ: 4.17% n: 4 2022-04-12 → 2026-07-31 | RXL Oct avg: 2.16% median: -0.08% win: 50% σ: 12.75% n: 4 2022-04-12 → 2026-07-31 | RXL Nov avg: 9.21% median: 9.33% win: 75% σ: 7.65% n: 4 2022-04-12 → 2026-07-31 | RXL Dec avg: -3.30% median: -3.97% win: 25% σ: 8.60% n: 4 2022-04-12 → 2026-07-31 |
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| VEEVVeeva Systems, Inc. | — → 0.38% | — |
| Holding | Before → after | Δ weight |
|---|---|---|
| LLYEli Lilly & Co. | 10.22% → 12.67% | +2.45 pp |
| UNHUnitedHealth Group, Inc. | 3.25% → 4.98% | +1.73 pp |
| IQMMProShares GENIUS Money Market ETF | 10.73% → 11.81% | +1.08 pp |
| ABBVAbbVie, Inc. | 5.02% → 5.57% | +0.55 pp |
| JNJJohnson & Johnson | 7.32% → 7.86% | +0.53 pp |
+30 more
| Holding | Before → after | Δ weight |
|---|---|---|
| BSXBoston Scientific Corp. | 1.39% → 1.04% | −0.36 pp |
| ABTAbbott Laboratories | 2.48% → 2.15% | −0.32 pp |
| ZTSZoetis, Inc. | 0.71% → 0.47% | −0.23 pp |
| HCAHCA Healthcare, Inc. | 1.04% → 0.86% | −0.18 pp |
| MCKMcKesson Corp. | 1.49% → 1.32% | −0.18 pp |
+10 more
| Holding | Before → after | Δ weight |
|---|---|---|
| Hologic, Inc. | 0.21% → — | — |
| MOHMolina Healthcare, Inc. | 0.10% → — | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Holdings of RXL currently on TickerStance stock-RS leaderboards.
Metrics matched 56 tickers across 59 holdings rows (86.7% of fund weight). Metrics as of 2026-08-24; holdings from the filing.